129 related articles for article (PubMed ID: 15253862)
1. Explanatory attributions of anxiety and recovery in a study of kava.
Abraham KC; Connor KM; Davidson JR
J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
[TBL] [Abstract][Full Text] [Related]
2. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
3. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
4. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
Volz HP; Kieser M
Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
[TBL] [Abstract][Full Text] [Related]
5. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
6. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
Boerner RJ; Sommer H; Berger W; Kuhn U; Schmidt U; Mannel M
Phytomedicine; 2003; 10 Suppl 4():38-49. PubMed ID: 12807341
[TBL] [Abstract][Full Text] [Related]
7. Kava treatment in patients with anxiety.
Geier FP; Konstantinowicz T
Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
Malsch U; Kieser M
Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
[TBL] [Abstract][Full Text] [Related]
9. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled study of Kava kava in generalized anxiety disorder.
Connor KM; Davidson JR
Int Clin Psychopharmacol; 2002 Jul; 17(4):185-8. PubMed ID: 12131602
[TBL] [Abstract][Full Text] [Related]
11. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
Witte S; Loew D; Gaus W
Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
[TBL] [Abstract][Full Text] [Related]
13. Kava-kava extract in anxiety disorders: an outpatient observational study.
Scherer J
Adv Ther; 1998; 15(4):261-9. PubMed ID: 10186945
[TBL] [Abstract][Full Text] [Related]
14. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
15. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
[TBL] [Abstract][Full Text] [Related]
16. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
[TBL] [Abstract][Full Text] [Related]
17. [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
Kinzler E; Krömer J; Lehmann E
Arzneimittelforschung; 1991 Jun; 41(6):584-8. PubMed ID: 1930344
[TBL] [Abstract][Full Text] [Related]
18. Kava.
Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
[No Abstract] [Full Text] [Related]
19. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
Ooi SL; Henderson P; Pak SC
J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
[TBL] [Abstract][Full Text] [Related]
20. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
Cribb L; Sarris J; Savage KM; Byrne GJ; Metri NJ; Scholey A; Stough C; Bousman CA
Phytother Res; 2023 Dec; 37(12):5897-5903. PubMed ID: 37767766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
